HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Panagiota Anyfanti Selected Research
Panagiota Anyfanti Research Topics
Disease
12
Hypertension (High Blood Pressure)
01/2019 - 11/2011
8
Rheumatoid Arthritis
04/2024 - 07/2012
8
Inflammation (Inflammations)
10/2023 - 01/2011
7
Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2018
6
Essential Hypertension
01/2020 - 01/2012
3
Atherosclerosis
01/2019 - 11/2017
3
Neoplasms (Cancer)
01/2012 - 01/2011
2
Thromboinflammation
10/2023 - 01/2022
2
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 01/2022
2
Vascular System Injuries
01/2022 - 12/2020
2
Thrombosis (Thrombus)
01/2022 - 01/2011
2
Masked Hypertension
01/2022 - 08/2014
2
Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2019
2
Microvascular Rarefaction
12/2019 - 08/2014
2
Fibrosis (Cirrhosis)
01/2019 - 01/2011
2
Sepsis (Septicemia)
11/2011 - 01/2011
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2024
1
Systemic Vasculitis
05/2024
1
Carotid Artery Diseases
04/2024
1
Hyperglycemia
01/2020
1
Necrosis
01/2020
1
Hematologic Neoplasms (Hematological Malignancy)
01/2019
1
Vascular Diseases (Vascular Disease)
01/2018
1
Arthritis (Polyarthritis)
07/2016
1
Pain (Aches)
07/2016
1
Dyslipidemias (Dyslipidemia)
01/2016
1
Insulin Resistance
01/2016
1
Lymphoma (Lymphomas)
08/2015
1
Cardiomegaly (Heart Hypertrophy)
05/2014
1
White Coat Hypertension
03/2013
1
Hyperaldosteronism (Conn Syndrome)
01/2012
1
Vascular Remodeling
01/2012
1
Adenoma (Adenomas)
01/2012
1
Neoplasm Metastasis (Metastasis)
01/2011
1
Ischemia
01/2011
1
Neutropenia
12/2010
Drug/Important Bio-Agent (IBA)
8
Biomarkers (Surrogate Marker)
IBA
05/2024 - 01/2018
6
Retinaldehyde (Retinal)
IBA
01/2019 - 03/2013
4
Cytokines
IBA
01/2020 - 11/2011
3
Albumins
IBA
01/2020 - 12/2018
3
Aldosterone
IBA
01/2018 - 01/2012
2
Janus Kinases
IBA
04/2024 - 12/2022
2
Antirheumatic Agents (DMARD)
IBA
04/2024 - 12/2022
2
Janus Kinase Inhibitors
IBA
04/2024 - 12/2022
2
Galectin 3 (LGALS3)
IBA
10/2023 - 01/2019
2
Interleukins
IBA
01/2020 - 05/2014
2
Glucose (Dextrose)
FDA Link
Generic
01/2019 - 11/2011
2
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
01/2018 - 06/2017
2
Antihypertensive Agents (Antihypertensives)
IBA
04/2014 - 01/2012
2
Tumor Necrosis Factor Inhibitors
IBA
05/2013 - 12/2010
1
Complement System Proteins (Complement)
IBA
05/2024
1
Complement Membrane Attack Complex (Membrane Attack Complex)
IBA
05/2024
1
Autoantibodies
IBA
05/2024
1
Indicators and Reagents (Reagents)
IBA
11/2022
1
Immunomodulating Agents
IBA
01/2021
1
Coagulants
IBA
12/2020
1
Collagen
IBA
01/2020
1
Fibronectins (Fibronectin)
IBA
01/2020
1
Interleukin-10 (Interleukin 10)
IBA
01/2020
1
Interleukin-12 (IL 12)
IBA
01/2020
1
Oxygen (Dioxygen)
IBA
12/2019
1
A-factor (Streptomyces)
IBA
01/2019
1
Metformin (Glucophage)
FDA Link
Generic
01/2019
1
Salts
IBA
01/2018
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2018
1
Cholesterol
IBA
06/2017
1
ametantrone (HAQ)
IBA
07/2016
1
Insulin (Novolin)
FDA Link
01/2016
1
C-Reactive Protein
IBA
01/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016
1
Radioisotopes (Radionuclides)
IBA
08/2015
1
Clay
IBA
05/2015
1
cardiotrophin 1
IBA
05/2014
1
Angiotensin Receptor Antagonists
IBA
04/2014
1
tabalumab
IBA
05/2013
1
Monoclonal Antibodies
IBA
05/2013
1
B-Cell Activating Factor
IBA
07/2012
1
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2012
1
Tissue Inhibitor of Metalloproteinase-2
IBA
01/2012
1
Matrix Metalloproteinases (MMPs)
IBA
01/2012
1
Sodium
IBA
01/2012
1
Metalloproteases (Metalloproteinases)
IBA
01/2012
1
Interleukin-6 (Interleukin 6)
IBA
01/2012
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2011
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2011
1
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
11/2011
1
Transcription Factors (Transcription Factor)
IBA
11/2011
1
Proteinase-Activated Receptors
IBA
01/2011
1
Anticoagulants
IBA
01/2011
1
Thrombin
FDA Link
01/2011
Therapy/Procedure
3
Lasers (Laser)
11/2022 - 01/2021
3
Therapeutics
01/2020 - 11/2011
2
Sympathectomy (Sympathectomies)
05/2012 - 11/2011
1
Cell Transplantation
01/2019
1
Nephrectomy
01/2012
1
Immunomodulation
11/2011